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ABSTRACT
Objectives To evaluate the performance and cost
effectiveness of the WHO recommendations of
incorporating risk-assessment scores and population
prevalence of Neisseria gonorrhoeae (NG) and Chlamydia
trachomatis (CT) into vaginal discharge syndrome (VDS)
algorithms.
Methods Non-pregnant women presenting with VDS
were recruited at a non-governmental sexual health clinic
in Soﬁa, Bulgaria. NG and CT were diagnosed by PCR and
vaginal infections by microscopy. Risk factors for NG/CT
were identiﬁed in multivariable analysis. Four algorithms
based on different combinations of behavioural factors,
clinical ﬁndings and vaginal microscopy were developed.
Performance of each algorithm was evaluated for
detecting vaginal and cervical infections separately. Cost
effectiveness was based on cost per patient treated and
cost per case correctly treated. Sensitivity analysis
explored the inﬂuence of NG/CT prevalence on cost
effectiveness.
Results 60% (252/420) of women had genital
infections, with 9.5% (40/423) having NG/CT. Factors
associated with NG/CT included new and multiple sexual
partners in the past 3 months, symptomatic partner,
childlessness and $10 polymorphonuclear cells per ﬁeld
on vaginal microscopy. For NG/CT detection, the
algorithm that relied solely on behavioural risk factors
was less sensitive but more speciﬁc than those that
included speculum examination or microscopy but had
higher correct-treatment rate and lower over-treatment
rates. The cost per true case treated using a combination
of risk factors, speculum examination and microscopy
was €24.08. A halving and tripling of NG/CT prevalence
would have approximately the inverse impact on the
cost-effectiveness estimates.
Conclusions Management of NG/CT in Bulgaria was
improved by the use of a syndromic approach that
included risk scores. Approaches that did not rely on
microscopy lost sensitivity but were more cost effective.
INTRODUCTION
The management of sexually transmitted infec-
tions (STIs) when resources are constrained relies
on the syndromic approach promoted by WHO.
1
The performance of this approach has been
extensively reviewed.
2 Concerns remain about the
management of vaginal discharge syndrome (VDS),
which aims to include treatment of cervicitis
caused by Neisseria gonorrhoeae (NG) and Chlamydia
trachomatis (CT) alongside treatment of vaginitis
caused by Trichomonas vaginalis (TV), bacterial
vaginosis (BV) and Candida spp. Critics have
argued that the syndromic approach lacks both
sensitivity and speciﬁcity, as most cervical infec-
tions are asymptomatic and only a minority of
women presenting with VDS have cervical
infections.
3
Rapid point-of-care diagnostic tests for NG or
CT would facilitate VDS management, but such
tests do not currently exist.
4 To improve algorithm
accuracy and to save costs WHO has suggested the
use of individual risk-assessment scores (RAS). RAS
are combinations of sociodemographic and behav-
ioural risk factors and clinical signs found to be
locally associated with cervical infections and/or
the results of simple laboratory or bedside tests.
Past evaluations of RAS have yielded mixed results,
with higher positive predictive values and better
cost-effectiveness proﬁles found in settings with
higher NG/CT prevalence.
5e14 Such ﬁndings imply
that effectiveness may not just vary between
countries, but also between settings within
a country. The most recent WHO STI guidelines
1
have recommended that RAS incorporate back-
ground cervical infection prevalence levels in the
target population. Moreover, to reduce costs, the
WHO guidelines have proposed modiﬁcations in
the management of vaginal infections, in particular
vulvo-vaginal candidiasis whose treatment is
expensive, but these recommendations have not
been validated in many settings.
After the demise of communism in the early
1990s, healthcare systems collapsed in many
Central and Eastern European countries, accompa-
nied by alarming rises of STIs and HIV.
15 16 Yet,
many countries have been reluctant to embrace
WHO policies perceived to be designed for devel-
oping countries.
17 In Bulgaria, there was a seven-
fold increase in reported syphilis cases between
1990 and 1994.
18 19 STI treatment could ofﬁcially
only be offered at government-controlled derma-
tovenereological centres. With only one centre per
region, many patients sought care in the unregu-
lated private sector, or resorted to self-medication
by obtaining over-the-counter antibiotics in phar-
macies.
20 National STI guidelines have only existed
for syphilis.
21 Introduction of syndromic manage-
ment has been resisted both by the Ministry of
Health and many dermatovenereological specialists
on grounds of lack of scientiﬁc validity.
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Health services researchIn 2000, the international non-governmental organisation
Médecins Sans Frontières Switzerland (MSF) established
a sexual health centre in Soﬁa, providing services to young, poor
and marginalised populations, such as homeless people and the
Roma population. The project involved Bulgarian clinicians and
scientists and stimulated the development of evidence-based
nationally relevant and acceptable STI guidelines. This study
was conducted to evaluate the performance and costs of various
approaches to managing vaginal and cervical infections for
women presenting with VDS, including the use of RAS.
Approaches were selected to represent varying levels of health-
care capacity in the country. We modelled the cost effectiveness
of each algorithm at different NG/CT prevalence levels. Results
were used to advocate incorporation of the syndromic approach
into the national guidelines. This process generated a number of
lessons for getting research into practice, which might be
relevant elsewhere.
PATIENTS AND METHODS
Between September 2001 and June 2002, consecutive non-
pregnant women aged 15 years and above attending the MSF
Sexual Health Centre with a clinically veriﬁed complaint of
vaginal discharge were enrolled. Consenting patients completed
a questionnaire about sexual and reproductive health and
behaviours and underwent a clinical and speculum examination.
Genital swabs were collected for vaginal pH reading (Spezia-
lindikator 4-7, Merck, Darmstadt, Germany) and detection of
amine odour for clinical diagnosis of BV,
22 microscopy for
vaginal polymorphonuclear (PMN) cell count and detection of
TV, BVand candidiasis (CA), and PCR assays for the detection of
cervical NG and CT. Blood samples were collected for syphilis
and HIV serologies, and rapid tests were performed on site.
Laboratory methods are described in the online supplementary
data. Women testing positive for HIV or syphilis serology were
managed according to existing Bulgarian Ministry of Health
guidelines. All patients received treatment according to the MSF
algorithm with WHO RAS (R1) and microscopy (algorithm 1,
ﬁgure 1) and followed WHO syndromic management guidelines.
Patients also received STI health education and counselling and
were offered condoms. Depending on PCR results, treatment for
NG and CTwas provided at a follow-up appointment.
Statistical methods
Risk factor analysis
We ﬁrst determined risk factors for NG/CT using univariable
analysis to obtain ORs and 95% CIs. Then, a stepwise backward
logistic regression was conducted, starting with all variables
with p values <0.25. Variables were removed from the model to
obtain a parsimonious model containing only those variables
with sufﬁciently strong associations (adjusted OR $2.0 or
p<0.10). The strength of the associations was tested with
Pearson’s c
2 (or Fisher’s exact test) for comparison of propor-
tions, analysis of variance for comparison of means and the
KruskaleWallis non-parametric test for comparison of medians.
Risk scores
Risk scores were developed by incorporating variables that
remained most signiﬁcantly associated with NG/CT in the
analysis above; each covariate was given a weighting propor-
tionate to the strength of its association (logn of the OR).
10 14
Risk scores (R2 to R4) were designed to reﬂect the capacity of
different levels of health provision in Bulgaria (online supple-
mentary table 1). Thus, R2 was based on socio-behavioural data
onlydthat is, when examination is not possible; R3 added
outcomes of a speculum examination; and R4 incorporated
clinical signs and results of microscopy, where this could be
done. These scores were incorporated in the treatment algo-
rithms 2, 3 and 4, respectively, which followed the format of the
most recent WHO algorithms (ﬁgures 2 and 3).
1
WHO guidelines recommend eliciting signs of pelvic inﬂam-
matory disease (PID), which have been shown to be associated
with NG/CT. In our study, women complaining of lower
abdominal pain were classiﬁed as having possible PID, and were
given treatment for NG/CTand for TV/BV, but not for CA. The
Figure 1 Algorithm 1 for Vaginal Discharge Syndrome management at the Me ´decins Sans Frontie `res (MSF) clinic in Soﬁa, Bulgaria, using the WHO
risk-assessment score and microscopy (R1). BV, bacterial vaginosis; CA, candidiasis; CT, Chlamydia trachomatis; KOH, potassium hydroxide; NG,
Neisseria gonorrhoea; TV, Trichomonas vaginalis.
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Health services researchgroup without lower abdominal pain underwent the RAS. In
this subgroup those with a positive score were considered at risk
for cervical infection and received treatment for NG/CT.
Algorithms performance
The validity of the four treatment algorithms was assessed by
comparing the treatment given against treatment that should
have been given using the ‘gold standard’ for each infection or
group of infections (ie, NG/CT, TV/BV and CA) (see online
supplementary data). Standard performance indicators (sensi-
tivity, speciﬁcity and positive predictive value (PPV)) were
calculated from two-by-two tables. We also estimated correct-
treatment rate (ie, the proportion of patients correctly identiﬁed
as requiring treatment or not), and the over-treatment rate (ie,
the proportion of non-infected patients who received treatment,
which is equal to 1 e speciﬁcity).
Economic analysis
We compared the costs of managing VDS using the different
algorithms. The costing analysis was conducted from the
provider’s perspective, considering MSF as the sole provider.
Financial and economic costs were the same because no goods or
services were donated. Costs were collected retrospectively from
MSF ﬁnancial accounts for the year 2002, and converted into
euros (€) using the ﬁxed exchange rate of 1.95 leva per euro.
Only incremental recurrent costs were estimated, assuming all
other costs remained equal. Infrastructure, training and super-
vision costs were therefore not included. Direct costs of labour,
diagnostic supplies and drugs were estimated using an ingredi-
ents-based approach, in which the total quantity of goods and
services used was estimated and then multiplied by the respec-
tive unit prices.
23 The cost of labour was determined through an
observational time allocation study and time units were multi-
plied by the relevant salary units of staff performing various
tasks (counsellor, clinician, laboratory technician). Costs of
inputs can be found in online supplementary tables 2 and 3. All
research-related costs were excluded. Total costs were divided by
the number of people treated to obtain the cost per patient, and
were divided by the number of laboratory-conﬁrmed cases to
obtain the cost per true case treated.
Weperformedasensitivityanalysisoftheperformanceandcost
effectiveness of the various management approaches using
different assumptions about the prevalence of NG/CTinfections.
Figure 2 Algorithms 2 and 3 for Vaginal Discharge Syndrome
management using the study-derived risk-assessment score without
speculum (R2, algorithm 2) or with speculum (R3, algorithm 3). BV,
bacterial vaginosis; CA, candidiasis; CT, Chlamydia trachomatis; NG,
Neisseria gonorrhoea; PID, pelvic inﬂammatory disease; TV, Tricho-
monas vaginalis.
Figure 3 Algorithm 4 for Vaginal Discharge Syndrome management using the study-derived risk-assessment score with microscopy (R4). BV,
bacterial vaginosis; CA, candidiasis; CT, Chlamydia trachomatis; KOH, potassium hydroxide; NG, Neisseria gonorrhoea; PID, pelvic inﬂammatory
disease; TV, Trichomonas vaginalis.
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Health services researchRESULTS
Overall, 495 women presented to the MSF clinic with
a complaint of vaginal discharge over the 9-month study period;
439 women were eligible for the study, and the presence of
abnormal discharge was ascertained in 424 (97%) women, all of
whom consented to enrol in the study. Participants had a mean
age of 23.9 years (range 16e54), 16% were cohabiting or married,
most (79%) had completed secondary school, their mean age at
sexual debut was 16.9 years (SD +/ 2.09), 13.4% reported
multiple partners in thepast monthand27%in thepastyear,and
26% had undergone a voluntary abortion in their life.
The prevalences of NG and CT were 0.7% and 9.2%, respec-
tively, with a combined NG/CT prevalence of 9.5% (40/423).
The prevalence of vaginal infections was 20.5% for CA, 2.9% for
TV, 35.1% for BVand for TV/BV 35.7%. Overall, 60% (252/420)
had a treatable vaginal or cervical infection (table 1).
Risk factors associated with NG/CT identiﬁed through
multivariable analysis are shown in table 2. Four factors were
elicited by interview, two clinical factors obtained during spec-
ulum examination and one laboratory-based factor (vaginal
PMN count). These factors were combined to form risk scores
R2 to R4.
Algorithms performance
Table 3 summarises the performance of the four algorithms
being tested against NG/CTand vaginal infections.
For NG/CT detection, the sensitivity of the WHO-derived
MSF algorithm (algorithm 1) was 85% while speciﬁcity and PPV
were quite low (39% and 13%, respectively). The inclusion of
speciﬁc risk factors found in the modelling analysis increased
sensitivity markedly up to 93e98% (where on-site microscopy
for PMN could be performed for algorithms 3 and 4). This was
accompanied by a large reduction in speciﬁcity (28% and 13% for
algorithms 3 and 4, respectively).
For TV/BV, the highest sensitivity was achieved by using
Amsel’s score including microscopy for ‘clue cells’ (94%, algo-
rithm 4). However, this strategy supposes that all women with
suspected PID should receive treatment for BV without micro-
scopic examination, which led to lower speciﬁcity and PPV (73%
and 66%, respectively) than algorithm 1.
For CA, sensitivity was highest when microscopy was added
(algorithm 1). Algorithm 4 had a low sensitivity (77%) because it
did not include on-site investigations for women suspected of
PID. Algorithms 2 and 3, which did not incorporate microscopy
and relied on the presence of the clinical sign vulval erythema to
provide treatment for CA,
1 had a low sensitivity (43%) and poor
speciﬁcity (54%).
Economic evaluation
Total costs of diagnosis and treatment for all 424 women varied
from €514 using algorithm 3 to €1504 using algorithm 4.
Algorithm 4 had the highest personnel costs owing to the
gynaecological examination and laboratory procedures, and the
highest drug costs owing to high over-treatment rates. The cost
per true NG/CT case treated relatively low (€24.08) using the
MSF algorithm (algorithm 1) (table 4). This strategy would have
treated 85% (34/40) of truly infected women, while treating
63% (269/424) of study participants. In contrast, algorithm 4
would have treated 86% (365/424) of all women, to correctly
treat 98% (39/40) of truly infected women, at a 60% higher cost
(€38.58) (table 4).
Impact of NG/CT prevalence on cost effectiveness
Cost effectiveness of the algorithms was modelled for different
NG/CT prevalences (table 4). Changes in NG/CT prevalence are
not expected to affect the actual performance of the tests, but to
impact the PPV, and thus, the cost effectiveness of the
approaches. PPV rose markedly with increasing prevalence (from
6e8% for low prevalence (5%) settings, up to 40% in the high
prevalence (30%) settings). Consequently, the cost effectiveness
of all strategies improved in the high prevalence settings. For
strategies that did not incorporate microscopy (algorithms 2 and
3), the cost per true case treated ranged from around €7 in high
prevalence settings to around €45 in low prevalence settings. For
algorithms 1 and 4, which incorporate both speculum exami-
nation and microscopy, the cost per true case treated ranged
from €8t o€73 in high and low prevalence settings, respectively.
Overall, algorithm 2 appeared to be the most cost effective but it
missed a larger proportion of true cases.
DISCUSSION
WereporttheﬁrststudyconductedinanEasternEuropeancountry
assessing the performance and cost effectiveness of various
approaches to treating women presenting with vaginal discharge
syndrome. This is also the ﬁrst study to evaluate comprehensively
the recommended WHO VDS algorithm, which includes a RAS,
Table 2 Factors associated with NG/CT infection in multivariable
analysis used in constructing risk assessments scores R2 to R4
Risk factors Adjusted OR (95% CI) p Value
From interview
Away from home in past 12 months 2.0 (0.9 to 4.1) 0.06
Not having children 4.0 (1.2 to 13.7) 0.03
New sexual partner or >1 sex partner in the
past 3 months
2.7 (1.3 to 5.5) <0.01
Symptomatic partner in the past month
(presence of urethral discharge/dysuria)
2.9 (0.9 to 9.0) 0.05
From speculum examination
Presence of cervical erythema or endo-
cervical mucopus
1.9 (0.9 to 4.1) 0.08
Presence of malodorous vaginal discharge 2.0 (0.9 to 4.1) 0.06
From vaginal microscopy
$10 PMN/HPF on vaginal smear 3.0 (1.3 to 7.3) 0.02
CT, Chlamydia trachomatis; NG, Neisseria gonorrhoeae; PMN/HPF, polymorphonuclear cells
per high power ﬁeld (microscopy).
Table 1 Prevalence of sexually transmitted and reproductive tract
infections among 424 women with vaginal discharge syndrome in
Soﬁa, Bulgaria
Pathogens
Women
n/N %
Cervical infections
Neisseria gonorrhoeae (NG) 3/423 0.7
Chlamydia trachomatis (CT) 39/423 9.2
Any NG and/or CT (NG/CT) 40/423 9.5
Vaginal infections
Candidiasis (CA) 87/424 20.5
Bacterial vaginosis (BV) 149/424 35.1
Trichomonas vaginalis (TV) 12/421 2.9
TV and/or BV 150/420 35.7
Any vaginal pathogens or condition
(TV/BV/CA)
235/420 56.0
Any vaginal or cervical infections 252/420 60.0
Serological infection
Syphilis (VDRL+/TPHA+) 10/422 2.4
HIV 0/424 0.0
TPHA, Treponema pallidum haemagglutination assay; VDRL, Venereal Diseases Research
Laboratory.
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Health services researchtheuseofbackgroundpopulationNG/CTprevalenceandclinically
based criteria for the management of candidiasis.
Performance and cost effectiveness of algorithms for NG/CT
detection
The NG/CT prevalence foundin thispopulation was surprisingly
high, similar to rates found in many developing nations,
11 24e27
although this was essentially due to high CT prevalence. Our
stringent testing for NG and CT by double PCR strengthens the
speciﬁcity of our results, perhaps at the expense of sensitivity.
Moreover, the Amplicor PCR has been known to lack sensitivity
for the detection of NG, although this has been observed with
urine rather than cervical samples.
28 Consistent with previous
studies, reports bywomen ofrecentchange ofpartner or multiple
sexual partnerships (considered high-risk behaviour indicators),
report of a symptomatic partner, childlessness and presence of
leucocytes in the vaginal smear were correlated with NG/CT
infections.
11 24e27
A NG/CT prevalence at around 10% falls within the ‘grey
zone’ of algorithm performance, since such prevalence usually
translates into low PPVs.
1 The algorithms using RAS had
passable performances (>60% sensitivity and speciﬁcity for
algorithm 2). Using the combination of speculum examination
and RAS (algorithms 1 and 3) increased sensitivity to 90%, but
reduced speciﬁcity. Similarly, the incorporation of simple
microscopy (algorithm 4) maximised sensitivity (98%) at the
expense of speciﬁcity and PPV. In public health, a balance has to
be found between sensitivity and speciﬁcity. Low algorithm
sensitivity results in many untreated infections, which place the
infected person at continued risk of persistent symptoms,
progression to more serious complications and further disease
transmission. Low speciﬁcity leads to overdiagnosis, which in
turn can increase the risk of adverse drug reactions, modify
normal vaginal ﬂora and increase treatment costs. Additionally,
with low PPV, women who do not have an STI will receive
a false-positive result and may suffer adverse psychosocial
Table 3 Performance of algorithms for the detection of cervical and vaginal infections at the Me ´decins Sans Frontie `res (MSF) clinic in Soﬁa, Bulgaria
Performance indicators, % (95% CI)
Algorithm Sensitivity Speciﬁcity PPV Correct treatment Overtreatment
NG/CT
1 (MSF) 85 (69 to 94) 39 (34 to 43) 13 (9 to 17) 43 (38 to 48) 61 (56 to 66)
2 (no speculum) 63 (46 to 77) 60 (55 to 65) 14 (9 to 20) 60 (56 to 65) 40 (35 to 45)
3 (speculum) 93 (73 to 98) 28 (24 to 33) 12 (9 to 14) 34 (30 to 39) 72 (67 to 76)
4 (microscopy and spec.) 98 (85 to 100) 13 (10 to 17) 11 (7 to 14) 21 (17 to 25) 87 (83 to 90)
TV/BV
1 (MSF) 88 (81 to 92) 94 (90 to 96) 89 (83 to 94) 92 (89 to 94) 6 (4 to 10)
2 and 3 (no speculum/speculum) 100 (97 to 100) 0 (0 to 2) 36 (32 to 41) 36 (32 to 41) 100 (98 to 100)
4 (microscopy and speculum) 94 (89 to 97) 73 (67 to 78) 66 (59 to 72) 80 (76 to 84) 27 (22 to 33)
CA
1 (MSF) 100 (95 to 100) 100 (98 to 100) 100 (95 to 100) 100 (99 to 100) 0 (0 to 1)
2 and 3 (no speculum/speculum) 43 (34 to 54) 54 (46 to 60) 22 (16 to 29) 52 (47 to 57) 46 (40 to 51)
4 (microscopy and speculum) 77 (67 to 85) 24 (20 to 30) 23 (19 to 28) 37 (32 to 41) 76 (70 to 80)
Note: Algorithms 2 and 3 were not combined for NG/CT but were combined for TV/BV because the outcome of speculum examination is not used to distinguish TV from BV.
BV, bacterial vaginosis; CA, candidiasis; CT, Chlamydia trachomatis; MSF, NG, Neisseria gonorrhoeae; PPV, positive predictive value; TV, Trichomonas vaginalis.
Table 4 Performance and cost effectiveness (in €) of alternative management strategies according to
prevalence of cervical (NG/CT) infections among 424 Bulgarian women with vaginal discharge syndrome
Algorithm 1: Algorithm 2: Algorithm 3: Algorithm 4:
MSF R1 with speculum
and microscopy
R2 without
speculum
R3 with
speculum
R4 with
microscopy
9.5% NG/CT prevalence (at MSF Soﬁa clinic)
PPV, % 13 14 12 11
No of patients treated 269 178 291 365
Cost per patient, € 1.93 0.93 2.01 3.55
Cost per true case treated, € 24.08 20.57 23.94 38.58
5% NG/CT prevalence
PPV, % 7 8 6 6
No of patients treated 264 174 309 363
Cost per patient, € 1.91 1.20 2.08 3.54
Cost per true case treated, € 45.05 38.33 44.87 72.61
20% NG/CT prevalence
PPV, % 26 28 24 22
No of patients treated 280 188 322 371
Cost per patient, € 1.97 1.25 2.12 3.57
Cost per true case treated, € 11.58 10.00 11.47 18.30
30% NG/CT prevalence
PPV, % 37 40 36 33
No of patients treated 290 198 331 376
Cost per patient, € 2.01 1.28 2.15 3.59
Cost per true case treated, € 7.86 6.85 7.76 12.27
CT, Chlamydia trachomatis; MSF, Me ´decins Sans Frontie `res; NG, Neisseria gonorrhoeae; PPV, positive predictive value; R, risk score.
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Health services researchconsequences. Speculum examination may appear simple, but it
is time consuming and is not always feasible in all primary
healthcare settings. In Bulgaria, however, incorporation of
speculum examination in primary care is desirable given the
observed gain in sensitivity. The study also demonstrated that
microscopy for vaginal PMN count, even using a low threshold,
actually added very little to sensitivity for the detection of
cervical infection, while greatly increasing the costs, and is thus
not recommended for routine management. The MSF/WHO or
RAS algorithms 1 and 2 appear to provide the best combination
of treatment coverage and cost effectiveness suitable for the
Bulgarian settings.
Performance of algorithms for vaginal infections
Unsurprisingly, the most common pathogens found among
women complaining of vaginal discharge were bacterial vagi-
nosis and T vaginalis (35.7% combined prevalence), while vulvo-
vaginal candidiasis was found in 20.5% of women. Evidence
suggests that BV is involved in the pathogenesis of PID, and
both BV and TV predispose to preterm delivery and possibly to
acquisition of HIV infection.
29 30 TV and BV are often much
more prevalent than NG or CT infections, both are strongly
correlated with symptoms and signs of abnormal vaginal
discharge, and are more easily and inexpensively treated. The
study demonstrated that diagnostic strategies that incorporated
microscopy performed well with sensitivity, speciﬁcity and PPV
all approaching 90%. However, where resources are constrained,
a presumptive treatment strategy with metronidazole to cover
both TV and BV for all women presenting with VDS might be
preferred, and would be cost effective.
Inﬂuence of NG/CT prevalence on the cost effectiveness of
algorithms
As expected, the PPVs of algorithms increased with higher
NG/CT prevalence, with improvements in cost effectiveness,
consistent with ﬁndings summarised in a recent review.
31 This
has consequences for the choice of case management strategies.
In situations or settings in which high sensitivity is to be
achieveddfor example, where prevalence of cervical infections is
expected to be high, the use of a combination of speculum
examination and risk assessment may be preferred. In situations
in which raising the PPV is a prioritydfor example, when
prevalence of cervical infection is low, the probability of further
transmission is low, or when potential adverse effects of false
positive results are high (eg, possible intimate partner violence in
low-risk women), the use of algorithms that only include RAS
may be preferred.
Implications for policy in Bulgaria
The relatively small sample size of the study, conducted at just
one NGO-led clinic limits the generalisability of the ﬁndings.
However, at the time, this was the ﬁrst comprehensive study of
vaginal discharge aetiologies in the country, particularly among
poor and marginalised populations. This evidence obtained with
local scientists, combined with the economic analysis, persuaded
policy makers and practitioners of the poor performance of
current management practices and of the need to introduce STI
management guidelines. A similar approach was used for the
adoption of STI syndromic management guidelines in
Azerbaijan.
32 Moreover, syndromic management appeared well
accepted by patients, as reported in separate patients’ satisfac-
tion surveys (data not shown). However, it took several months
of training and practice for the MSF clinical team to accept
syndromic management procedures, which highlights the deeply
entrenched habits among some STI clinicians.
33
In conclusion, this study showed that algorithms for VDS
relying on a relatively simple questionnaire and physical
examination have good sensitivity for NG/CT and acceptable
speciﬁcity that can greatly simplify the care of patients with STI
in Bulgaria. However, the intermediate prevalence of cervical
infections in this population leads to low PPVs and relatively less
favourable cost-effectiveness indicators. Accurate and cheap
point-of-care diagnostics tests for gonorrhoea and Chlamydia
would prove useful in this and similar settings. The process of
collaborative research to generate local evidence can greatly
facilitate the adoption and implementation of international
treatment guidelines.
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